Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...
Viatris’ $3.335 Billion Combination of Biosimilars Portfolio with Biocon Biologics
Repligen Corporation’s Acquisition of Polymem S.A.
Goodwin Procter advised Repligen Corporation on the deal. Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced the acquisition of Polymem S.A., a leading...
Monte Rosa Therapeutics’ $95 Million Series C Financing
Goodwin Procter LLP advised Monte Rosa Therapeutics on the deal. Monte Rosa Therapeutics, a biotechnology company focused on discovering and developing precision medicines that degrade disease-causing...